Parkinsonian DisordersInorganic ChemicalsSupranuclear Palsy, ProgressiveMultiple System AtrophyParkinson DiseaseLevodopaParkinson Disease, SecondaryResearchAntiparkinson Agents1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineGlobus PallidusHypokinesiaMuscle RigidityBrain ChemistrySubthalamic NucleusBipolar DisorderDyskinesia, Drug-InducedBrain InjuriesBrainOxidopamineSubstantia NigraBrain NeoplasmsMental DisordersTremorBrain MappingCorpus StriatumDeep Brain StimulationDyskinesiasExtrapyramidal TractsDopamineAnxiety DisordersCarbidopaMood DisordersBasal GangliaDopamine AgentsMovement DisordersResearch Support as TopicOlivopontocerebellar AtrophiesNeuronsResearch DesignMagnetic Resonance ImagingEthics, ResearchBenserazideMazindolDisease Models, AnimalDiagnostic and Statistical Manual of Mental DisordersResearch Personnel